Author

David Lang

Trường (David) Lăng, as Founder and CEO of Viettonkin, dedicates his extensive expertise to fostering robust trade and investment bridges between Southeast Asia and global partners. With over 17 years of experience, he has successfully guided over 3,000 FDI projects and advised Fortune Global 500 corporations on complex market entry and expansion strategies. His impactful work includes providing technical assistance to governments, developing innovative initiatives like Viettonkin's 'FDI Desks,' and maintaining strategic relationships with central authorities and NGOs. David's thought leadership in economic development and policy advocacy empowers businesses worldwide to confidently navigate and thrive in emerging markets.

228 articles

Indonesia Pharma Regulation: Certification and Market…

Industry Insights

Indonesia Pharma Regulation: Certification and Market Insights for Business Operators

The Indonesian regulations seemed straightforward until we dug deeper. A Fortune Global 500 client was planning their market entry strategies, confident they…

Nov 28, 2025 7 min read

Foreign Investment Restrictions in Indonesia’s Pharmaceutical…

FDI & Investment

Foreign Investment Restrictions in Indonesia’s Pharmaceutical Sector: What Investors Must Know

The call came at 7 PM on a Friday. Our client’s planned pharma investment in Indonesia was in Jeopardy. They had just…

Nov 28, 2025 7 min read

Health Supplement Registration in Indonesia: Essentials…

Market Entry

Health Supplement Registration in Indonesia: Essentials for Market Entry Success

Three months into a planned market entry, a client’s health supplement registration was rejected. It wasn’t an issue with labeling or a…

Nov 27, 2025 7 min read

How to Start a Supplement Company:…

Market Entry

How to Start a Supplement Company: From Idea to Market Success in Indonesia

The call came at 7 PM on a Friday. A new foreign investor, ready to launch a high-end wellness industry brand, was…

Nov 27, 2025 7 min read

FDI & Investment

The Consolidation Wave: How M&A in Pharmaceutical Markets is Reshaping Vietnam

Vietnam’s pharmaceutical industry and healthcare sectors are no longer just growing; they are consolidating. In recent years, mergers and acquisitions (M&A) have…

Nov 26, 2025 6 min read

M&A in Indonesia’s Pharmaceutical Sector: A…

Market Entry

M&A in Indonesia’s Pharmaceutical Sector: A Guide for Strategic Buyers

The call came at 7 PM on a Friday. Our client’s multi-million-dollar acquisition in Indonesia, a key part of their strategy for…

Nov 26, 2025 8 min read

Navigating Foreign Pharma Investment Opportunities in…

FDI & Investment

Navigating Foreign Pharma Investment Opportunities in Indonesia’s Health Sector

Three months into a planned pharma investment in Indonesia, we hit an unexpected roadblock. A Fortune 500 client’s legal team was panicking…

Nov 26, 2025 10 min read

Pharma Policy Frameworks Shaping Global Drug…

Market Entry

Pharma Policy Frameworks Shaping Global Drug Regulation in 2025

During my cooperation with UNICEF, I learned something crucial that has shaped how I approach every Fortune 500 consultation: government pharma policy…

Nov 25, 2025 7 min read

FDI

Tighter Vietnam Pharmacy Practice Requirements: Overcoming Challenges, Seizing Opportunities

Recent shifts in Vietnam’s regulatory landscape signal a deliberate move towards international standards in pharmacy practice, presenting both a complex challenge and…

Nov 24, 2025 6 min read

Indonesia’s Pharmaceutical Industry Uncovered: A Strategic…

FDI & Investment

Indonesia’s Pharmaceutical Industry Uncovered: A Strategic Guide for Investors

The labyrinthine nature of Indonesian regulations often presents a deceptively straightforward facade, a lesson hard-learned through extensive on-the-ground experience. A client, a…

Nov 24, 2025 13 min read

Ready to expand in Southeast Asia?

Talk to an ASEAN expert who has guided 2,000+ companies into the region.

Get a consultation See our capabilities